Medical Affairs Asia Forum 2014

440
-1

Published on

Medical Affairs teams in Asia’s diverse markets need to collaborate with R&D and understand the science, the business and the regulations. They need to constantly think strategically and communicate effectively.
• How can Medical Affairs teams be even more impactful in enhancing your company’s scientific reputation?
• How can you better communicate the value of your products to KOLs and Healthcare professionals?
• What makes a successful Medical Affairs team in Asia?
Get the answers and more at the 3rd MEDICAL AFFAIRS FORUM ASIA {link} - the region’s longest running strategy forum where leading medical affairs professionals share best practices, discuss common issues and learn from industry experts to enhance scientific reputation and better communicate the value of products to KOLs.

http://www.pharmaconasia.com/medical-affairs-forum-asia

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
440
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Medical Affairs Asia Forum 2014

  1. 1. Produced by: International Marketing Partner: Media Partners: www.pharmaconasia.com Life Sciences IBC LIFE SCIENCES PARKROYAL on Beach Road, Singapore 26-29 August 2014 Asia’s Longest Running Medical Affairs Strategy Forum becomes even BIGGER... Advancing Effective Communication and Collaboration with Internal and External Stakeholders Supporting Associations: Featuring Insights from: What’s New in 2014? 85% new speakers Roundtable discussions for a relaxed discussion among peers on key areas in Medical Affairs Dialogue between Medical Affairs and Marketing to increase synergies and align goals Part of: Pre-Conference Workshops: 26 August 2014 | Tuesday A. Critical Evaluation of Scientific information and Its Transformation into Meaningful Communication B. Clinical and Medical Affairs Management: Lessons from two Blockbusters in Ophthalmology Post-Conference Workshops: 29 August 2014 | Friday C. Cultivating A Sound Medical - Marketing Partnership D. Effective Engagement of Stakeholders in Chronic Diseases Dr Rene Rueckert Global Program Medical Director Novartis Switzerland Dr Samuel Dryer Chairman of the Board Medical Science Liaison Society, USA Dr Kamlesh Patel General Manager Abbott Healthcare India Dr Elena Rizova Vice President Asia Pacific External Innovation, Johnson & Johnson Singapore Dr Victoria Elegant VicePresident,Medical,Clinical and Regulatory Affairs Baxter Healthcare China Dr Jacqueline Mao Director,ASPACRegionalMedical Lead Consumer Healthcare Wyeth Pharmaceuticals China Sponsors:
  2. 2. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com CCOONFERENNFERENCE DCE DAAY OY ONENE 27 AUGUST 2014 Wednesday 8:50 Welcome from IBC Asia & Speed Networking 9:00 Chairman’s Welcome and Opening Remarks Asia Pharmaceutical Market Outlook & Regulatory Updates 9:10 Asia Pharmaceutical Investment Opportunities & Development • Where is the Asian pharmaceutical market heading towards? • What are the investment and market opportunities available in Asia? • How are pharma companies in Asia coping with intensifying competition and investment from overseas? • Selecting the best business model, communication and operations to maximize market share in Asia • How regional integration has affected product launch and marketing in the prescription and non-prescription market Moderator: Dr Joshi Venugopal, Managing Director, Singapore & Asian Emerging Markets, Novartis Panelists: Jun Bao, Senior Vice President & Chief Business Officer, Shenogen Pharma Group, China Billy Sarvanantham Urudra, Chief Commercial Officer, CCM Pharmaceuticals Sdn Bhd, Malaysia Dr Narendra Vutla, Executive Vice President & Head, R&D – Wellness, Oral Health & Site Operations, GSK Consumer Healthcare, India Carl Firth, CEO, Aslan Pharmaceuticals, Singapore 10:00 Asia’s Evolving Regulatory Landscape & Development • Current initiatives and regulatory trends in Southeast Asia • International models, frameworks and standards for Asia to adopt • Regulatory trends and their impact on R&D investment • Recent pharma marketing regulations changes and expecting new guideline and compliance process under AEC • Are pharma companies ready for the implementation and the liberalization of health care services? • Current regulatory challenges faced and how they can be tackled • ASEAN harmonization and to what extent will it drive Asian innovation? Moderator: Dr Samual Dryer, Chairman of the Board, Medical Science Liaison Soceity, USA Panelists: Joy Chen, Director, Regulatory Affairs, Reckitt Benckiser, Singapore Ariel Valencia, Deputy Director, Food & Drugs Administration, Department of Health, Philippines Koichi Miyazaki, Senior Director, Regulatory Affairs Group, Asia Development Department, Daiichi Sankyo, Japan 10:40 Morning Networking and Refreshment Break Responding to Industry Changes through the Medical Affairs Function 11:25 Welcome by Chairman Dr Elena Rizova, Vice President Asia Pacific External Innovation, Johnson & Johnson, Singapore 11:30 What Makes Medical Affairs Landscape Different inToday’s Dynamic Cross-Functional Team? • Trends and challenges from a Medical Affairs perspective • Understanding medical practices and the unmet needs • The right competencies that support cross functional teams of therapeutic expertise, commercial, regulatory, R&D, legal, compliance etc. • Collaborations and setting expectations with different team members • Cultural differences across borders Dr Chern Searn Lim, Country Head of Medical Affairs, Pacific Rim, Shire, Singapore 12:10 Assessing the Medical Affairs Function: How to Hit Our KPI • What are the roles, expectations and responsibilities of Asia’s MSLs? • Structuring and coordinating medical affairs activities • Strategies to be effective ambassadors across the scientific and public health communities • Measuring what matters through MSL metrics Dr AjayTiku, RegionalMedicalDirector,CardiovascularDisease, Asia Pacific, Middle East & Africa, Bristol Myers Squibb, Singapore 12:50 Speed Networking 13:00 Networking Lunch Dr Rene Rueckert, GlobalProgramMedicalDirector, Novartis, Switzerland Dr Anish Desai, Director Medical & Clinical Affairs, Johnson & Johnson, India 14:00 Learning from the Evolution of Sales, Marketing and Medical Affairs • Evolution of our current selling model • Emergence of Medical Affairs • Bridging the divide • Future outlook from a General Manager’s perspective Dr Joshi Venugopal, Managing Director, Singapore & Asian Emerging Markets, Novartis Effective Medical Communications and Digital Engagement of KOLs 14:40 MaximizeKOLEngagementthroughEffectiveMSLTraining • Target, cultivate and develop relationships by delivering value • Develop engagement programs that benefit stakeholders • Achieve better positioning to improve trust and effective communication • Leverage external partnerships to share information and reach internal and external stakeholders Dr Samuel Dryer, Chairman of the Board, Medical Science Liaison Society, USA 15:20 Afternoon Networking and Refreshment Break 15:40 Engagement and Development of Key Stakeholders Through Strong Medical Communications • Stakeholder identification • Ideas to engage Stakeholders • Successes & lessons learned for Asia Senior Executive, Nucleus Holdings, Singapore Innovative Talent Management 16:10 Combating Shortage ofTrained Professionals and Keeping the Good Ones • What is the extent of the problem and how is it being addressed in Asia? • Will successful models from the west work in the Asian context? • How to prioritise resources to mitigate the lack of experienced and well-trained medical affairs professionals Dr Elena Rizova, Vice President Asia Pacific External Innovation, Johnson & Johnson, Singapore Interactive Round Table Discussions 16:30 Choose your preferred topic and discuss in a relaxed roundtable setting with peers • Medical Affairs for Oncology Facilitator: Dr Anish Desai, DirectorMedical&ClinicalAffairs, Johnson & Johnson, India___________________________________________________________________________________________________________________ • Medical Affairs for Medical Devices Facilitator: Christine Lim, Senior Director, Johnson & Johnson Medical Devices and Diagnostics, Singapore___________________________________________________________________________________________________________________ • Medical Affairs for Consumer Products Facilitator: JacquelineMao, Director,ASPACRegionalMedical Lead Consumer Healthcare, Wyeth Pharmaceuticals, China 17:30 Chairman’s Closing and End of Day One VISIONARYKEYNOTEREGULATORYPANEL VIPLUNCH TABLES
  3. 3. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com CCOONFERENNFERENCE DCE DAAY TY TWWOO 28 AUGUST 2014 Thursday KEYNOTE 8:50 Chairman’s Opening Remarks Dr Samuel Dryer, Chairman of the Board, Medical Science Liaison Society, USA Internal Stakeholder Engagement, Collaboration and Communication 9:00 Medical Affairs and Marketing Collaboration • What are the common barriers between medical affairs and marketing team? • What medical affairs teams are looking for in aligning marketing campaigns with business goals • Best practices in internal and external communication to address the correct needs of patients and prescribers Dr Narendra Vutla, Executive Vice President & Head, R&D- Wellness, Oral Health & Site Operations, GSK Consumer Healthcare, India 9:40 Bridging the Gaps in Engaging with Internal Stakeholders • Cross functional opportunities and challenges: where are the conflict points? • Where are the gaps that lead to misalignment between marketing and medical affairs? • Ensuring continuous feedback to boosting communication • How do we link synergies and reconcile differences? • Managing different priorities and expectations to create synergy for win-win solutions Moderator: Dr Salman Bokhari, Managing Director, Sidrapex, Singapore Panelists: Dr AjayTiku, RegionalMedicalDirector,CardiovascularDisease, Asia Pacific, Middle East & Africa, Bristol Myers Squibb, Singapore Dr Kamlesh Patel, General Manager, Medical, Abbott Healthcare, India Dr Narendra Vutla, Executive Vice President & Head, R&D – Wellness, Oral Health & Site Operations, GSK Consumer Healthcare, India 10:20 Morning Networking and Refreshment Break Scientific Communication Strategies and Clinical Development 11:00 Clinical Development and Medical Affairs: Realizing Synergies for Successful Drugs • Identify unmet medical need and develop integrated strategies to address • Clinical development resource planning- using synergies between development and medical affairs • Improve efficacy of clinical development and medical affair strategies • Effective life-cycle management strategy Dr Rene Rueckert, Global Program Medical Director, Novartis; Eyegnos Consulting, Switzerland 11:40 Keeping up with Complex Scientific and Medical Information • Transforming scientific data to useful, relevant information • Improve quality and flow of information • Skills needed to communicate complex, scientific data into useful information to doctors and patients • Communicating evidence-based value to stakeholders Dr Kamlesh Patel, General Manager, Medical, Abbott Healthcare, India 12:20 Reserve for Wiley Martine Docking, Commercial Director, Asia Pacific, Wiley, Singapore 12:50 Networking Lunch 14:00 Developing a Scientific Communication Plan and Customer Oriented Strategy • Develop and implement medical affairs/scientific communications strategies and tactics • Ensuring compliance while growing the MSL role • Empowering the MSL involvement throughout the communication plan • Increasing product awareness by incorporating scientific information sharing • Addressing challenges to achieve set goals Dr Anish Desai, Director Medical & Clinical Affairs, Johnson & Johnson, India 14:40 Strengthening Medical Affairs through Investigator- Initiated (IITs) Studies in Asia • Including IITs to enhance the research process and involve physicians • Why investigator-led studies benefit doctors • Strategies for successful IITs • Compliance guidelines from IITs Dr Victoria Elegant, Vice President, Medical, Clinical and Regulatory Affairs, Baxter Healthcare, China Strategies for Success while Keeping Compliant 15:20 Improve Relationships, Build Credibility and Motivate KOLs • Ensuring smooth communication and work relationships with KOLs • Optimizing KOL engagements through networking and value exchanges • Continually improving communication and coordination • Establishing criteria to evaluate KOL engagement Dr Aamir Shaikh, CEO, Assansa Health, India 16:00 Afternoon Networking and Refreshment Break 16:30 Effective Engagement of KOL in a Therapeutic Area • Developing an innovative Medical Affairs team structure centered on a particular therapeutic area • Create and deliver therapeutic training programs to be used by medical affairs Dr Arun Gowda, Director, Phamax, Switzerland The Future of Medical Affairs 17:10 Future Directions of the Medical Affairs Team • Addressing talent management issues before looking at expanding reach • Where are the biggest opportunities for medical affairs professionals? • How do we approach common challenges faced in the region? • Where should be the biggest investment to improve efficiencies? Panelists: Dr Anish Desai, Director Medical & Clinical Affairs, Johnson & Johnson, India DrVictoriaElegant, VicePresident,Medical,Clinical&Regulatory Affairs, Baxter Healthcare, China Dr Marion Munk, Research Fellow, Feinberg School of Medicine, USA, Eyegnos Consulting, Switzerland 18:00 End of the 3rd Annual Medical Affairs Asia Summit PANELDISCUSSIONS PANELDISCUSSIONS
  4. 4. Dr Marion Munk, Ophthalmologist, Austria ; Eyegnos Consulting, Switzerland Dr Munk is an ophthalmologist with broad clinical interest, a focus on clinical research in retina, age-related macular degeneration and cystoid macular edema applying state of the art imaging as optical coherence tomography and functional magnetic resonance tomography. She has been involved in many global clinical trials, is a consultant to the pharmaceutical industry and avid teacher, lecturer and presenter. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com WORKSHOPS OBJECTIVE: To understand and to improve the ability to critically evaluate published scientific evidence in developing meaningful scientific communication. OUTLINE: • Introduction into critical appraisal of scientific articles • Questions to ask when critically appraising a research article- Steps in the Evidence-Based Process • Recognizing the strengths and weaknesses of the paper • Common statistical presentations as well as sources of error and limitation- Numerical language for clinical evidence • Quantifying the risk of benefit/harm and interpretation of results related to relevant theory • Paraphrasing the significance of the paper in 3 or 4 sentences ABOUT YOUR WORKSHOP LEADER: Dr Kamlesh Patel, General Manager, Medical, Abbott Healthcare, India Dr Kamlesh Patel has over 12 years of experience in the pharmaceutical industry. Prior to his current role as General Manager - Medical Affairs and Head of Pharmacovigilance in Abbott HealthCare, India, he was with Ranbaxy-Daichii Sankyo, Merck and Boehringer-Ingelheim. Kamlesh played key roles in developing regulatory strategies to ensure faster approvals and late phase clinical development programs as a part of KOL engagement, launching innovative products and the formulation of consensus and advocacy across multiple therapeutic areas. He is heavily involved in planning, developing and implementing ethics, compliance and the core medico marketing projects/initiatives across different therapeutic areas. ABOUT YOUR WORKSHOP LEADERS: Dr Rene Rueckert, Global Program Medical Director, Novartis, Switzerland Dr Rueckert is leading the global development in ophthalmology at Novartis AG, Basel, Switzerland and is founder and CEO of eyegnos consulting. He previously held senior positions at Novartis in marketing and medical affairs in different areas. Previously, Dr Rueckert was the Global Clinical Leader at Bayer AG in Berlin, where he established and built the ophthalmology franchise and led the development of Eylea a now blockbuster drug for retinal diseases, driving all aspects from preclinical to regulatory and medical affairs to establishing clinical, GMA and brand teams. Before joining Bayer, Dr Rueckert was academic lecturer and led a research group in Immunology. He is author of many peer-reviewed publications, cited 2000-times and served as doctor in Internal Medicine and Dermatology. He obtained his MD degree with highest honors at the Charité Berlin, Germany. He holds a board certification in Biochemistry and was trained in immunology and genetics at the Charité and at Yale University. In Asia’s challenging health care and rapidly evolving pharmaceutical industry environment, a sound Medical - Marketing partnership is vital, and often demonstrably linked to‘success’. Such a partnership will not occur by chance, and must be consciously cultivated. Moreover, this partnership and its benefits must be perceived to exist by and within the Medical - Marketing teams, the internal organization, and the external stakeholders and customers. This half-day workshop will address the following broad themes and related specific issues: • Evolving Medical - Marketing Interaction – Cultivating a Sound Partnership • Seeking Common Ground – Shared Vision, Strategic Thinking, Deliverables • Effective Execution –  Crafting Medical Development Plans Aligned with Brand Plans • Building and Nurturing an Effective Medical – Marketing Team - Leadership, Trust, Communication, Accountability, and Results ABOUT YOUR WORKSHOP LEADER: Dr Aamir Shaikh, CEO, Assansa Health, India Dr Aamir Shaikh, is the Founder of Assansa, a consultancy which specializes in designing and delivering professional development programs and customized learning experiences for the health care industry and academia in the following core health care and pharmaceutical industry domains: pharmaceutical medicine; medical / clinical research, education and practice; and health care leadership development. He was previously Director, Medical Affairs & Research for Pfizer India where he nurtured, led and grew teams of Medical Affairs professionals across a variety of medical affairs related domains in varied functional and therapeutic areas. Current challenges to pharmaceutical companies in terms of managing stakeholders are magnified in the emerging markets due to the local conditions. Apart from the clinical stakeholders or physicians, there are other stakeholders that are becoming critical to success in these markets. Payers, policy makers, patient groups all have a stake in these markets and a well thought through strategy is needed to effectively manage all of them. However, some key questions remain: • Why is it important to engage with local stakeholders? • How do you engage the different stakeholders in a manner that there is a benefit to everyone involved? • What are the potential initiatives that can keep people engaged? • How do you sustain and nurture this engagement to for a long term engagement? OUTLINE: • The requirements of a scientific market access and the role of stakeholders in it • Identifying the key stakeholders for chronic disease • CA(2)RE – A framework for engaging stakeholders • Benefits of nurturing the engagement • Case study: Effective engagement of stakeholders for policy change ABOUT YOUR WORKSHOP LEADER: Dr Arun Gowda Dr Gowda is currently Director – FSRC (focus scientific research center) a part of Phamax AG, where he is working towards developing unbiased and comprehensive understanding of local issues through a scientific framework to simplify and resolve issues in patients’ access to healthcare in high-growth economies. Previously Arun was with Nokia as the Global Product Lead, Health and Wellness managing the mHealth product for high-growth economies. Arun is a physician by training and has worked in various fields of the healthcare sector. He has supported leading pharma and FMCG companies on work in epidemiology, literature reviews, white papers & poster presentations, business & clinical intelligence, market research, stakeholder engagement, brand positioning, and digital marketing strategy. Critical Evaluation of Scientific information and Its Transformation into Meaningful Communication Pre-Conference Workshop A 26 August 2014 (Tuesday) 9.00am – 12.30pm Pre-Conference Workshop B 26 August 2014 (Tuesday) 1.30pm – 5.00pm Cultivating a Sound Medical — Marketing Partnership Post-Conference Workshop C 29 August 2014 (Friday) 9.00am – 12.30pm Effective Engagement of Stakeholders in Chronic Diseases Post-Conference Workshop D 29 August 2014 (Friday) 1.30pm – 5.00pm OBJECTIVE: This workshop will present the clinical and the industry perspective on developing breakthrough innovations in new indications and markets with two Ophthalmology products as an example. OUTLINE: • Identification of unmet medical need and development of strategies to address this need • Combination of development and medical affair strategies • Market preparation and entry strategy • Lifecycle management Clinical and Medical Affairs Management: Lessons from two Blockbusters in Ophthalmology
  5. 5. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com IBC LIFE SCIENCES PARKROYAL on Beach Road, Singapore 26-29 August 2014 Advancing Effective Communication and Collaboration with International Stakeholders COUNTRY: ■ Singapore 40% ■ Malaysia 10% ■ India 10% ■ US 10% ■ Europe 10% ■ China 5% ■ Indonesia 5% ■ Thailand 5% ■ Philippines 3% ■ Vietnam 2% Who Should Attend: With a market size of over $200 billion, Asia’s diverse pharma markets grow even stronger with rising populations and incomes and the growing incidence of chronic diseases. Medical Affairs has stepped up into becoming a central function to ensure success in these markets by engaging KOLs with relevant scientific information. Moreover, Medical Affairs teams need to collaborate with R&D and understand the science, the business and the regulations. They need to constantly think strategically and communicate effectively. How can Medical Affairs teams be even more impactful in enhancing your company’s scientific reputation? How can you better communicate the value of your products to KOLs and Healthcare professionals? What makes a successful Medical Affairs team in Asia? Get the answers and more at the 3rd MEDICAL AFFAIRS FORUM ASIA – the region’s longest running strategy forum where leading medical affairs professionals share best practices, discuss common issues and learn from industry experts to enhance scientific reputation and better communicate the value of products to KOLs. Sponsorship Opportunities Tailored sponsorship packages are available to meet your unique marketing & business development requirements, enabling you to achieve the maximum ROI from your association with this event. For more information about placing your brand and profile top-of-mind to Medical Affairs teams in Asia, contactYvonne Leong onTel: +65 6508 2489 / Yvonne.leong@ibcasia.com.sg Why You Must Attend This Year’s Event Improve communication and relationships with KOLs in key therapeutic areas to meet your KPIs Be updated on the regulatory and cultural landscapes in Asia’s key markets Learn from industry thought leaders and peers with global and regional experience in Medical Affairs Dialogue with internal stakeholders to better communicate and align business strategies Hear from experienced Medical Affairs Directors on nurturing talents and building successful Medical Affairs teams in Asia INDUSTRY: ■ Pharma Companies 70% ■ CROs 13% ■ Medical Device 10% ■ Medical Communication/KOL Management Cost 5% ■ Staffing and Outsourcing companies 2% “Speakers are really experienced, with practical information” ~ Pfizer “Very interactive with a case based learning approach” ~ Abbott Healthcare Part of:
  6. 6. WHO SHOULD ATTEND? • Head of Medical Affairs • Medical Affairs Directors • MSLs • Chief Medical Officer • Scientific Directors • Medical Directors • Medical and Scientific Affairs Executives IBC LIFE SCIENCES 4 Successful Events Under 1 Roof! 26 - 29 AUGUST 2014 | PARKROYAL ON BEACH ROAD, SINGAPORE What is PharmaCon? The Pharmaceutical Congress Asia (PharmaCon) is the leading annual event that brings together Government, pharmaceutical companies and suppliers in Asia across: 4 Conferences 10 Workshops 4 Days of value-packed information Hours of networking opportunities The dynamic program and networking platform aims to enable companies to develop strong partnerships, drive innovation and growth, as well as winning products and services, in Asia’s growing pharmaceutical industry. Asia’s premier Pharma R&D conference is designed for professionals in the pharmaceutical R&D sector to find out the latest investment, partnership and collaboration opportunities, challenges facing drug discovery and clinical development and how to improve R&D innovation and productivity in Asia. WHO SHOULD ATTEND? Senior level professionals from: Designed for regulatory professionals in the pharmaceutical industry to come together to discuss effective regulatory strategies for product access into Asia and also globally as well as to gain clarity on the complex and ever changing regulations in the region. WHO SHOULD ATTEND? Professionals dealing with: • Global/Regional Regulatory Affairs • Regulatory Compliance • Regulatory Submissions & Publishing • Pharmacovigilance • Market Access Designed for senior executives from marketing in prescription and consumer health sectors, the conference pinpoints key success factors in strategizing pricing, distribution, advertising & promotion and product differentiation strategy in this competitive market.This event is Asia’s one and only platform to provide updated and in-depth evaluation on marketing strategies in the pharmaceutical industry. WHO SHOULD ATTEND? • CEO • Chief Marketing Officer • President/Managing Director/Vice President of Asia • Country Manager • Regional Marketing Director • Head of Corporate Planning • Head of Commercialization • Head of Marketing & Sales • Head of Market Access • Head of Business Development • Head of Multi-Channel Marketing • Head of Digital Marketing • Head of Product Development • Head of Packaging and Labeling • Head of Procurement & Sourcing • Head of Compliance MEDICAL AFFAIRS FORUM ASIA is the region’s longest running medical affairs forum where best practices are shared and common issues with like- minded peers are discussed. This event will bring insights on how to be more effective in enhancing your company’s scientific reputation and communicating the value of your products. • R&D • Drug Discovery • Clinical Trial and Development • Business Development • Partnerships & Licensing • Strategic Alliance Management • Strategy & Portfolio Management • Investment • Mergers & Acquisitions REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
  7. 7. ENJOY SUBSTANTIAL SAVINGS WITH OUR MULTIPLE BOOKING DISCOUNT! REGISTER NOW! FAX BACK TO +65 6508 2407 HOTEL INFORMATION DATA PROTECTION PAYMENT TERMS CANCELLATIONS / SUBSTITUTION IMPORTANT NOTE 6 EASY WAYS TO REGISTER Email register@ibcasia.com.sg Customer Service Hotline +65 6508 2401 Fax +65 6508 2407 Web www.pharmaconasia.com ❑ Yes! I/We will attend the 3rd Annual Medical Affairs Forum Asia 2014 | 26 – 29 August 2014, ParkRoyal on Beach Road, Singapore REGNO.200108203N 3RD ANNUAL MEDICAL AFFAIRS FORUM ASIA 2014 ❑ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in. RESERVE YOUR PLACE TODAY! CREDIT CARD PAYMENTS The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at www.pharmaconasia.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name and details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest confidence, please do not send payment details by email. Credit card contact: Department: Direct phone number: Email: P46248 Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd ❑ I am paying by bank transfer (copy attached) ❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted) Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry date, registration and payment must be received by the cut-off date. • Payment by bankers draft or cheque in S$ or US$ should be made in favour of “IBC Asia (S) Pte Ltd” and mailed to: IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06 Singapore 238164 Attn: The Accounts Receivable Team • Payment by bank transfer in S$ or US$ made payable to: IBC Asia (S) Pte Ltd A/C No.:147-059513-001 (S$) A/C No.:260-457866-178 (US$) The Hongkong and Shanghai Banking Corporation Limited 21 Collyer Quay, HSBC Building Singapore 049320 Bank Swift Code: HSBCSGSG Bank Code: 7232 • Payment by Credit Card (AMEX, VISA or MasterCard). The best way to pay by credit card is through our secure portal built into the website. To pay by phone please indicate the contact name and details below and our Customer Services Team will call within 24 hours to take payment. Please do not send credit card information by email. SAVE WITH THE EARLY BIRD & SPECIAL RATES! The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Occasionally, your details may be obtained from or shared with external companies who wish to communicate with you offers related to your business activities. If you do not wish your details to be used for this purpose, please contact our Database Department at Email: database@ibcasia.com.sg, Tel: +65 6508 2400 or Fax: +65 6508 2408. Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event. Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407). Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC assumes no further liability or obligation, beyond the refund of the paid registration fee, in the event of postponement or cancellation by IBC. MAIL the attached registration form with your cheque to IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Scan the QR Code with your smartphone and register today Early Bird Rate Register & pay on or before 20 Jun 2014 FEE PER DELEGATE Special Rate Register & pay on or before 18 Jul 2014 Group Rate (3 or more delegates) Normal Rate Register & pay after 18 Jul 2014 ❑ 2 Day Conference only SGD 3,895 SGD 4,095 SGD 4,295 SGD 3,795❑ 4 Day Package: 2 Day Conference + All Workshops GROUP BONUS – Register 3 Delegates from the same company and the 4th Delegate attends FREE! SGD 2,595 SGD 2,795 SGD 2,995 SGD 2,495 • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate. • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel. • Registration fees are subject to the prevailing government tax Who is Head of your Department? Who is Head of Training? Company Information Company Name: Address: Main Business/Activity: Postal Code: Please photocopy for additional delegates FREE GROUPDISCOUNT Delegate 1 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 2 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 3 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 4 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: ❑ 3.5 Day Package: 2 Day Conference + 3 Workshops ❑ A ❑ B ❑ C ❑ D SGD 3,295 SGD 3,495 SGD 3,695 SGD 3,195 PARKROYAL on Beach Road 7500 Beach Road, Singapore 199591 Hotel mainline: +65 6505 5666 Contact Person: Teo Hui Ling Tel: +65 6505 5696 Email: teo.huiling@parkroyalhotels.com SGD 3,595 SGD 3,795 SGD 3,995 SGD 3,495 ❑ 3 Day Package: 2 Day Conference + 2 Workshops ❑ A ❑ B ❑ C ❑ D ❑ 2.5 Day Package: 2 Day Conference + 1 Workshop ❑ A ❑ B ❑ C ❑ D SGD 2,995 SGD 3,195 SGD 3,395 SGD 2,895 4 Successful Events Under 1 Roof 180+ Attendees to Network With 4+ Days of Expert Knowledge Sharing 80+ Expert Pharmaceutical Stakeholders & Key Decision Makers 15+ Interactive Formats to Get To Know Your Peers & Customers 1 Joint Exhibition Area Part of:

×